SCHEMBL4605230

SCHEMBL4605230

N#Cc1ccc(C(=O)c2sc3ccccc3c2OCc2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SENP2 Q9HC62 13/20 0.51
SENP1 Q9P0U3 13/20 0.51
SENP5 Q96HI0 12/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.44
F10 P00742 1/20 0.41
PTPRC P08575 1/20 0.40
PTPN1 P18031 1/20 0.40
PRSS12 P56730 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRA5 P31644 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602746 0.90 SENP2 (0.46) SENP2SENP1SENP5
SCHEMBL4604279 0.88 SENP2 (0.51) SENP2SENP1SENP5
SCHEMBL4604237 0.87 SENP2 (0.48) SENP2SENP1SENP5
SCHEMBL4604692 0.87 SENP2 (0.50) SENP2SENP1SENP5
SCHEMBL4605388 0.86 SENP2 (0.51) SENP2SENP1SENP5ESR1
SCHEMBL4604678 0.86 SRD5A2 (0.46) SENP2SENP1SENP5
SCHEMBL4603341 0.85 KDM4E (0.48) SENP2SENP1SENP5F10PRSS12
SCHEMBL4604470 0.85 CYP1A2 (0.46) SENP2SENP1SENP5F10PRSS12
SCHEMBL4603362 0.85 SENP2 (0.43) SENP2SENP1SENP5
SCHEMBL4604236 0.85 SENP2 (0.52) SENP2SENP1SENP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685122-B1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2008-07-09 EP claimed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US claimed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US claimed
EP-1685122-B1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2008-07-09 EP disclosed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
EP-1685122-A1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GmbH (DE) 2006-08-02 EP disclosed
WO-2005054226-A1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066680-A1 Benzofurans and benzothiophenes INSR, GPR119, IGF1R SENP2 4103/4885SENP1 3205/4885SENP5 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.